Pfizer Inc. (NEO: PFE)

Market Cap	214.70B
Revenue (ttm)	80.12B
Net Income (ttm)	5.74B
Shares Out	n/a
EPS (ttm)	1.00
PE Ratio	37.42
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	72,760
Open	11.95
Previous Close	11.95
Day's Range	11.95 - 12.28
52-Week Range	11.40 - 14.73
Beta	0.62
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 4, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and po...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 88,000
• Stock Exchange: Cboe Canada
• Ticker Symbol: PFE

Financial Performance

In 2023, Pfizer's revenue was $58.50 billion, a decrease of -41.70% compared to the previous year's $100.33 billion. Earnings were $2.12 billion, a decrease of -93.25%.

Financial numbers in USD